Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study

OBJECTIVE: Plasma miRNAs represent potential minimally invasive biomarkers to monitor and predict outcomes from chemotherapy. The primary goal of the current study—consisting of patients with recurrent, platinum-resistant ovarian cancer—was to identify the changes in circulating miRNA concentrations...

Descripción completa

Detalles Bibliográficos
Autores principales: Benson, Eric A., Skaar, Todd C., Liu, Yunlong, Nephew, Kenneth P., Matei, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612782/
https://www.ncbi.nlm.nih.gov/pubmed/26485143
http://dx.doi.org/10.1371/journal.pone.0141279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612782/
https://www.ncbi.nlm.nih.gov/pubmed/26485143
http://dx.doi.org/10.1371/journal.pone.0141279

Ejemplares similares